Giant scaffolding protein AHNAK1 interacts with β-dystroglycan and controls motility and mechanical properties of schwann cells

GLIA

Volumn 62, Issue 9, 2014, Pages 1392-1406

  von Boxberg, Ysander ^a,b   Soares, Sylvia ^a,b   Féréol, Sophie ^c   Fodil, Redouane ^d   Bartolami, Sylvain ^e   Taxi, Jacques ^a,b   Tricaud, Nicolas ^e   Nothias, Fatiha ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b and Centre National de la Recherche Scientifique Unité Mixte de Recherche 8246   (France)

^c INSERM U955   (France)

^d Creteil Hospital   (France)

^e HÔPITAL SAINT ELOI   (France)

Author keywords

Atomic force microscopy; Dystroglycan; Myelin; Remak fibers; ShRNA knockdown

Indexed keywords

AHNAK1 PROTEIN; BETA DYSTROGLYCAN; F ACTIN; LAMININ; MYELIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; AHNAK PROTEIN, MOUSE; DYSTROGLYCAN; MEMBRANE PROTEIN; SMALL INTERFERING RNA; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOMECHANICS; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOSKELETON; ELECTRON MICROSCOPY; GLIA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYELINATED NERVE; MYELINATION; NERVE FIBER; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SCHWANN CELL; SCHWANN CELL CULTURE; SCIATIC NERVE; ULTRASTRUCTURE; ACTIN FILAMENT; ANIMAL; CELL CULTURE; CELL MOTION; ECHOGRAPHY; ELASTICITY; GENE SILENCING; GENETICS; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; METABOLISM; MYELIN SHEATH; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACTIN CYTOSKELETON; ANIMALS; AXONS; CELL MOVEMENT; CELLS, CULTURED; DYSTROGLYCANS; ELASTICITY; GENE KNOCKDOWN TECHNIQUES; MEMBRANE PROTEINS; MICE, KNOCKOUT; MICROSCOPY, ATOMIC FORCE; MYELIN SHEATH; NEOPLASM PROTEINS; NERVE FIBERS, MYELINATED; RNA, SMALL INTERFERING; SCHWANN CELLS; SCIATIC NERVE;

EID: 84904282910     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22685     Document Type: Article

References (71)

1. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. 1995. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 11:274-280.
2. Benaud C, Gentil BJ, Assard N, Court M, Garin J, Delphin C, Baudier J. 2004. AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J Cell Biol 164:133-144.
3. Berti C, Bartesaghi L, Ghidinelli M, Zambroni D, Figlia G, Chen ZL, Quattrini A, Wrabetz L, Feltri ML. 2011. Non-redundant function of dystroglycan and beta1 integrins in radial sorting of axons. Development 138:4025-4037.
4. Bouquet C, Ravaille-Veron M, Propst F, Nothias F. 2007. MAP1B coordinates microtubule and actin filament remodeling in adult mouse Schwann cell tips and DRG neuron growth cones. Mol Cell Neurosci 36:235-247.
5. Boxberg YV. 1988. Protein analysis on two-dimensional polyacrylamide gels in the femtogram range: Use of a new sulfur-labeling reagent. Anal Biochem 169:372-375.
6. Bray D. 1979. Mechanical tension produced by nerve cells in tissue culture. J Cell Sci 37:391-410.
7. Bunge RP, Bunge MB. 1978. Evidence that contact with connective tissue matrix is required for normal interaction between Schwann cells and nerve fibers. J Cell Biol 78:943-950.
8. Byers TJ, Lidov HG, Kunkel LM. 1993. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 4:77-81.
9. Canadas P, Laurent VM, Oddou C, Isabey D, Wendling S. 2002. A cellular tensegrity model to analyse the structural viscoelasticity of the cytoskeleton. J Theor Biol 218:155-173.
10. Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA. 2006. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 66:1181-1190.
11. Chen YJ, Spence HJ, Cameron JM, Jess T, Ilsley JL, Winder SJ. 2003. Direct interaction of beta-dystroglycan with F-actin. Biochem J 375:329-337.
12. Colognato H, ffrench-Constant C, Feltri ML. 2005. Human diseases reveal novel roles for neural laminins. Trends Neurosci 28:480-486.
13. Cornbrooks CJ, Carey DJ, McDonald JA, Timpl R, Bunge RP. 1983. In vivo and in vitro observations on laminin production by Schwann cells. Proc Natl Acad Sci USA 80:3850-3854.
14. Cotter L, Ozcelik M, Jacob C, Pereira JA, Locher V, Baumann R, Relvas JB, Suter U, Tricaud N. 2010. Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination. Science 328:1415-1418.
15. Court FA, Hewitt JE, Davies K, Patton BL, Uncini A, Wrabetz L, Feltri ML. 2009. A laminin-2, dystroglycan, utrophin axis is required for compartmentalization and elongation of myelin segments. J Neurosci 29:3908-3919.
16. Court FA, Sherman DL, Pratt T, Garry EM, Ribchester RR, Cottrell DF, Fleetwood-Walker SM, Brophy PJ. 2004. Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431:191-195.
17. Court FA, Zambroni D, Pavoni E, Colombelli C, Baragli C, Figlia G, Sorokin L, Ching W, Salzer JL, Wrabetz L, Feltri ML. 2011. MMP2-9 cleavage of dystroglycan alters the size and molecular composition of schwann cell domains. J Neurosci 31:12208-12217.
18. Cox EA, Huttenlocher A. 1998. Regulation of integrin-mediated adhesion during cell migration. Microsc Res Tech 43:412-419.
19. de Morree A, Droog M, Grand Moursel L, Bisschop IJ, Impagliazzo A, Frants RR, Klooster R, van der Maarel SM. 2012. Self-regulated alternative splicing at the AHNAK locus. FASEB J 26:93-103.
20. Dempsey BR, Rezvanpour A, Lee TW, Barber KR, Junop MS, Shaw GS. 2012. Structure of an asymmetric ternary protein complex provides insight for membrane interaction. Structure 20:1737-1745.
21. Dumitru CA, Bankfalvi A, Gu X, Zeidler R, Brandau S, Lang S. 2013. AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma. PLoS One 8:e56420.
22. Feltri ML, Wrabetz L. 2005. Laminins and their receptors in Schwann cells and hereditary neuropathies. J Peripher Nerv Syst 10:128-143.
23. Fereol S, Fodil R, Barnat M, Georget V, Milbreta U, Nothias F. 2011. Micropatterned ECM substrates reveal complementary contribution of low and high affinity ligands to neurite outgrowth. Cytoskeleton (Hoboken) 68:373-388.
24. Fereol S, Fodil R, Laurent VM, Balland M, Louis B, Pelle G, Henon S, Planus E, Isabey D. 2009. Prestress and adhesion site dynamics control cell sensitivity to extracellular stiffness. Biophys J 96:2009-2022.
25. Freiburg A, Trombitas K, Hell W, Cazorla O, Fougerousse F, Centner T, Kolmerer B, Witt C, Beckmann JS, Gregorio CC, Granzier H, Labeit S. 2000. Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ Res 86:1114-1121.
26. Gentil BJ, Delphin C, Benaud C, Baudier J. 2003. Expression of the giant protein AHNAK (desmoyokin) in muscle and lining epithelial cells. J Histochem Cytochem 51:339-348.
27. Gillespie CS, Sherman DL, Blair GE, Brophy PJ. 1994. Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12:497-508.
28. Goebbels S, Oltrogge JH, Wolfer S, Wieser GL, Nientiedt T, Pieper A, Ruhwedel T, Groszer M, Sereda MW, Nave KA. 2012. Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. EMBO Mol Med 4:486-499.
29. Haase H, Alvarez JP, D, Doller A, Behlke J, Erdmann J, Hetzer R, Regitz-Zagrosek V, Vassort G, Morano I 2005. Ahnak is critical for cardiac Ca(V)1.2 calcium channel function and its beta-adrenergic regulation. FASEB J 19:1969-1977.
30. Haase H, Pagel I, Khalina Y, Zacharzowsky U, Person V, Lutsch G, Petzhold D, Kott M, Schaper J, MIorano 2004. The carboxyl-terminal ahnak domain induces actin bundling and stabilizes muscle contraction. FASEB J 18:839-841.
31. Han H, Kursula P. 2014. Periaxin and AHNAK nucleoprotein 2 form intertwined homodimers through domain swapping. J Biol Chem. 2014, Mar 27, in press. doi: 10.1074/jbc.M114.554816.
32. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, Tome FM, Schwartz K, Fardeau M, Tryggvason K, Guicheney P. 1995. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 11:216-218.
33. Hohaus A, Person V, Behlke J, Schaper J, Morano I, Haase H. 2002. The carboxyl-terminal region of ahnak provides a link between cardiac L-type Ca2+ channels and the actin-based cytoskeleton. FASEB J 16:1205-1216.
34. Hsu YC, Chen HY, Yuan S, Yu SL, Lin CH, Wu G, Yang PC, Li KC. 2013. Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity. BMC Med 11:106.
35. Huang Y, de Morree A, van Remoortere A, Bushby K, Frants RR, Dunnen JT, van der Maarel SM. 2008. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum Mol Genet 17:1855-1866.
36. Huang Y, Laval SH, van Remoortere A, Baudier J, Benaud C, Anderson LV, Straub V, Deelder A, Frants RR, den Dunnen JT, Bushby K, van der Maarel SM. 2007. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J 21:732-742.
37. James M, Nuttall A, Ilsley JL, Ottersbach K, Tinsley JM, Sudol M, Winder SJ. 2000. Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin. J Cell Sci 113:1717-1726.
38. Kim IY, Jung J, Jang M, Ahn YG, Shin JH, Choi JW, Sohn MR, Shin SM, Kang DG, Lee HS, Bae YS, Ryu do H, Seong JK, Hwang GS. 2010. 1H NMR-based metabolomic study on resistance to diet-induced obesity in AHNAK knock-out mice. Biochem Biophys Res Commun 403:428-434.
39. Kobayashi K, Izawa T, Kuwamura M, Yamate J. 2012. Dysferlin and animal models for dysferlinopathy. J Toxicol Pathol 25:135-147.
40. Komuro A, Masuda Y, Kobayashi K, Babbitt R, Gunel M, Flavell RA, Marchesi VT. 2004. The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells. Proc Natl Acad Sci USA 101:4053-4058.
41. Kouno M, Kondoh G, Horie K, Komazawa N, Ishii N, Takahashi Y, Takeda J, Hashimoto T. 2004. Ahnak/Desmoyokin is dispensable for proliferation, differentiation, and maintenance of integrity in mouse epidermis. J Invest Dermatol 123:700-707.
42. Lamoureux P, Buxbaum RE, Heidemann SR. 1989. Direct evidence that growth cones pull. Nature 340:159-162.
43. Laurent VM, Henon S, Planus E, Fodil R, Balland M, Isabey D, Gallet F. 2002. Assessment of mechanical properties of adherent living cells by bead micromanipulation: Comparison of magnetic twisting cytometry vs optical tweezers. J Biomech Eng 124:408-421.
44. Lee SM, Sha D, Mohammed AA, Asress S, Glass JD, Chin LS, Li L. 2013. Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1C. Hum Mol Genet 22:1755-1770.
45. Leong S, Nunez AC, Lin MZ, Crossett B, Christopherson RI, Baxter RC. 2012. iTRAQ-based proteomic profiling of breast cancer cell response to doxorubicin and TRAIL. J Proteome Res 11:3561-3572.
46. Lim HJ, Kang DH, Lim JM, Kang DM, Seong JK, Kang SW, Bae YS. 2013. Function of Ahnak protein in aortic smooth muscle cell migration through Rac activation. Cardiovasc Res 97:302-310.
47. Marg A, Haase H, Neumann T, Kouno M, Morano I. 2010. AHNAK1 and AHNAK2 are costameric proteins: AHNAK1 affects transverse skeletal muscle fiber stiffness. Biochem Biophys Res Commun 401:143-148.
48. Matza D, Badou A, Jha MK, Willinger T, Antov A, Sanjabi S, Kobayashi KS, Marchesi VT, Flavell RA. 2009. Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis. Proc Natl Acad Sci USA 106:9785-9790.
49. Matza D, Badou A, Kobayashi KS, Goldsmith-Pestana K, Masuda Y, Komuro A, McMahon-Pratt D, Marchesi VT, Flavell RA. 2008. A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation. Immunity 28:64-74.
50. McKee KK, Yang DH, Patel R, Chen ZL, Strickland S, Takagi J, Sekiguchi K, Yurchenco PD. 2012. Schwann cell myelination requires integration of laminin activities. J Cell Sci 125:4609-4619.
51. Meintanis S, Thomaidou D, Jessen KR, Mirsky R, Matsas R. 2001. The neuron-glia signal beta-neuregulin promotes Schwann cell motility via the MAPK pathway. Glia 34:39-51.
52. O'Toole M, Lamoureux P, Miller KE. 2008. A physical model of axonal elongation: Force, viscosity, and adhesions govern the mode of outgrowth. Biophys J 94:2610-2620.
53. Ozcelik M, Cotter L, Jacob C, Pereira JA, Relvas JB, Suter U, Tricaud N. 2010. Pals1 is a major regulator of the epithelial-like polarization and the extension of the myelin sheath in peripheral nerves. J Neurosci 30:4120-4131.
54. Pankonien I, Otto A, Dascal N, Morano I, Haase H. 2012. Ahnak1 interaction is affected by phosphorylation of Ser-296 on Cavbeta(2). Biochem Biophys Res Commun 421:184-189.
55. Patzko A, Shy ME. 2011. Update on Charcot-Marie-tooth disease. Curr Neurol Neurosci Rep 11:78-88.
56. Relucio J, Tzvetanova ID, Ao W, Lindquist S, Colognato H. 2009. Laminin alters fyn regulatory mechanisms and promotes oligodendrocyte development. J Neurosci 29:11794-11806.
57. Royuela M, Chazalette D, Hugon G, Paniagua R, Guerlavais V, Fehrentz JA, Martinez J, Labbe JP, Rivier F, Mornet D. 2003. Formation of multiple complexes between beta-dystroglycan and dystrophin family products. J Muscle Res Cell Motil S 24:387-397.
58. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Cohn RD, Williamson RA, Sluka KA, Sherman DL, Brophy PJ, Schmelzer JD, Low PA, Wrabetz L, Feltri ML, Campbell KP. 2003. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron S 38:747-758.
59. Salim C, Boxberg YV, Alterio J, Fereol S, Nothias F. 2009. The giant protein AHNAK involved in morphogenesis and laminin substrate adhesion of myelinating Schwann cells. Glia 57:535-549.
60. Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR. 2010. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 70:3780-3790.
61. Sherman DL, Brophy PJ. 2005. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 6:683-690.
62. Sherman DL, Wu LM, Grove M, Gillespie CS, Brophy PJ. 2012. Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth. J Neurosci 32:9419-9428.
63. Shtivelman E, Cohen FE, Bishop JM. 1992. A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. Proc Natl Acad Sci USA 89:5472-5476.
64. Sotgia F, Bonuccelli G, Bedford M, Brancaccio A, Mayer U, Wilson MT, Campos-Gonzalez R, Brooks JW, Sudol M, Lisanti MP. 2003. Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo. Biochemistry 42:7110-7123.
65. Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP. 1994. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem 269:13729-13732.
66. Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S, Xu X, Esper RM, Loeb JA, Shrager P, Chao MV, Falls DL, Role L, Salzer JL. 2005. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47:681-694.
67. von Boxberg Y, Salim C, Soares S, Baloui H, Alterio J, Ravaille-Veron M, Nothias F. 2006. Spinal cord injury-induced up-regulation of AHNAK, expressed in cells delineating cystic cavities, and associated with neoangiogenesis. Eur J Neurosci 24:1031-1041.
68. Wang N, Tolic-Norrelykke IM, Chen J, Mijailovich SM, Butler JP, Fredberg JJ, Stamenovic D. 2002. Cell prestress. I. Stiffness and prestress are closely associated in adherent contractile cells. Am J Physiol Cell Physiol 282:C606-616.
69. Wendling S, Oddou C, Isabey D. 1999. Stiffening response of a cellular tensegrity model. J Theor Biol 196:309-325.
70. Yu WM, Yu H, Chen ZL, Strickland S. 2009. Disruption of laminin in the peripheral nervous system impedes nonmyelinating Schwann cell development and impairs nociceptive sensory function. Glia 57:850-859.
71. Zacharias U, Purfurst B, Schowel V, Morano I, Spuler S, Haase H. 2011. Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release. J Muscle Res Cell Motil 32:271-280.